Skip to main content
Search hero banner

Search results

Showing 1581 - 1600 of 1965 results

After your experiment clayton

After your experiment

Following your experiment at the Australian Synchrotron there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

Capabilities ANSTO Facilities

Capabilities

ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.

Faisal headshot
Nuclear Medicine

Faisal studied Electrical engineering at the University of Queensland and started their career in a role that specialised in integration of control systems in factories, large-scale rock crushing machinery, and marine luxury yachts.

Dr Justin Kimpton
Lead Scientist - Advanced Diffraction & Scattering beamlines

Role at ANSTO

Design and Innovation Lecturer
Design and Innovation Lecturer

David Mesa is a product design engineer who has worked on many innovations and new product development projects. As a designer, he helped other companies solve their problems through design.

Sherry Headshot
Graduate Engineer

Sherry entered university, torn between the allure of science and the hands-on practicality of engineering. This lead her into the field of Material Science and Engineering.

Greg Storr
Board member

Dr Storr has worked for over 40 years in nuclear science and technology in a range of positions spanning operations, research and executive management.

Dr Bruce Cowie
Principal Scientist - Soft x-ray spectroscopy

Role at ANSTO

Dr Miles Apperley
Group Executive Nuclear Safety, Security and Stewardship

In June 2022 Miles was appointed to a new role of Group Executive Nuclear Safety, Security and Stewardship with responsibility for all nuclear safety and security operations at ANSTO as well as coordination of al

Krishant Deo Profile Photo
Radiochemist

Krishant holds a PhD in Medicinal Chemistry, specialising in the design and development of novel platinum(IV)-based anticancer agents, where he has contributed to the development of a new class of compounds that is currently undergoing p

Pagination